XML 90 R69.htm IDEA: XBRL DOCUMENT v3.20.4
Collaborations - Bayer HealthCare Pharmaceuticals Inc. (Details)
$ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
country
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues $ 25,424 $ 23,362 $ 23,747
US [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues $ 18,496 17,224 18,358
Collaborative Arrangement with Bayer [Member] | Nexavar [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Number of countries product is marketed and sold | country 100    
Collaborative Arrangement with Bayer [Member] | Nexavar [Member] | US [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration, royalty percentage 30.00%    
Collaborative Arrangement with Bayer [Member] | Nexavar [Member] | NonUs,ExcludingJapan [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration, royalty percentage 30.00%    
Collaborative Arrangement with Bayer [Member] | Nexavar [Member] | Other revenues [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration profit   210 164
Collaborative Arrangement with Bayer [Member] | Royalty [Member] | Other revenues [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues $ 217 $ 79 $ 91